Retrieve available abstracts of 18 articles: HTML format
Single Articles
November 2025
YUAN X, Zhang T, Zheng X, Zhang Y, et al [Corrigendum] Overexpression of SET oncoprotein is associated with tumor
progression and poor prognosis in human gastric cancer.
Oncol Rep. 2025;54:143. PubMedAbstract available
October 2025
ZHU X, Jia L, Kuai X, Tang Q, et al High expression of eIF4A1 promotes angiogenesis through the NF?kappaB/VEGFA pathway
and predicts poor prognosis in gastric cancer.
Oncol Rep. 2025;54:118. PubMedAbstract available
September 2025
LU S, Ma Y, Sun T, Ren R, et al [Retracted] Expression of alpha?fetoprotein in gastric cancer AGS cells contributes
to invasion and metastasis by influencing anoikis sensitivity.
Oncol Rep. 2025;54:112. PubMedAbstract available
August 2025
GOMEZ-VALENZUELA F, Silva I, Retamal IN, Garcia-Bloj B, et al Comprehensive in?silico molecular analysis of early?onset gastric cancer
identifies novel genes implicated in disease characterization and progression
(Review).
Oncol Rep. 2025;54:98. PubMedAbstract available
July 2025
QIU X, Pan T, Kuang T, Shen Y, et al DEPP1: A prognostic biomarker linked to stroma?rich and immunosuppressive
microenvironment, promoting oxaliplatin resistance in gastric cancer.
Oncol Rep. 2025;54:82. PubMedAbstract available
June 2025
CHEN P, Zhao D, Wang W, Zhang Y, et al [Corrigendum] High expression of RELM-alpha correlates with poor prognosis and
promotes angiogenesis in gastric cancer.
Oncol Rep. 2025;53:61. PubMedAbstract available
LI Y, Wang K, Wei Y, Yao Q, et al [Retracted] lncRNA?MIAT regulates cell biological behaviors in gastric cancer
through a mechanism involving the miR?29a?3p/HDAC4 axis.
Oncol Rep. 2025;53:69. PubMedAbstract available
January 2025
YUN H, Dong F, Wei X, Yan X, et al Role and value of the tumor microenvironment in the progression and treatment
resistance of gastric cancer (Review).
Oncol Rep. 2025;53:14. PubMedAbstract available
October 2024
ZHU ZM, Li ZR, Huang Y, Yu HH, et al [Corrigendum] DJ?1 is involved in the peritoneal metastasis of gastric cancer
through activation of the Akt signaling pathway.
Oncol Rep. 2024;52:138. PubMedAbstract available
XU G, Meng L, Yuan D, Li K, et al [Retracted] MEG3/miR?21 axis affects cell mobility by suppressing
epithelial?mesenchymal transition in gastric cancer.
Oncol Rep. 2024;52:140. PubMedAbstract available
August 2024
YAN H, Qiu C, Sun W, Gu M, et al [Retracted] Yap regulates gastric cancer survival and migration via
SIRT1/Mfn2/mitophagy.
Oncol Rep. 2024;52:108. PubMedAbstract available
February 2024
WANG Y, Zhang H, Ge S, Fan Q, et al [Retracted] Effects of miR?138?5p and miR?204?5p on the migration and
proliferation of gastric cancer cells by targeting EGFR.
Oncol Rep. 2024;51:18. PubMedAbstract available
November 2023
GONG YC, Ren GL, Liu B, Li F, et al [Retracted] miR?206 inhibits cancer initiating cells by targeting EHF in gastric
cancer.
Oncol Rep. 2023;50:197. PubMedAbstract available
October 2023
WANG JB, Jin Y, Wu P, Liu Y, et al [Corrigendum] Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses
proliferation and epithelial mesenchymal transformation of gastric cancer cells.
Oncol Rep. 2023;50:187. PubMedAbstract available
July 2023
WANG L, Wu C, Xu J, Gong Z, et al GC‑MSC‑derived circ_0024107 promotes gastric cancer cell lymphatic metastasis via
fatty acid oxidation metabolic reprogramming mediated by the
miR‑5572/6855‑5p/CPT1A axis.
Oncol Rep. 2023;50:138. PubMedAbstract available
May 2023
ZENG H, Wang J, Xu B, Deng H, et al Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in
gastric diffuse large B‑cell lymphoma.
Oncol Rep. 2023;49:88. PubMedAbstract available
WANG H, Xiong M, Hu Y, Sun Y, et al [Retracted] MicroRNA‑19b inhibits proliferation of gastric cancer cells by
targeting B‑cell CLL/lymphoma 3.
Oncol Rep. 2023;49:104. PubMedAbstract available
April 2023
SUN DZ, Wei PK, Yue XQ Xiaotan Sanjie decoction normalizes tumor permissive microenvironment in gastric
cancer (Review).
Oncol Rep. 2023;49:74. PubMedAbstract available